We are live on ! Find out more
AWGLSCP

ABG-WTT Global Life Science Capital Partners Portfolio holdings

AUM $12.3M
1-Year Est. Return 3.13%
This Fund
S&P 500
This Quarter Est. Return
+169.14%
1 Year Est. Return
-3.13%
3 Year Est. Return
+108.96%
5 Year Est. Return
-90.91%
10 Year Est. Return
–
AUM
$51.3M
AUM Growth
+$30.5M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RYZB
1
DELISTED
RayzeBio, Inc. Common Stock
RYZB
$48.4M 94.38%
778,922
– –
MDVL
2
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$1.35M 2.63%
300,588
– –
RPID icon
3
Rapid Micro Biosystems
RPID
$86.2M
$768K 1.5%
1,038,296
– –
LUNG icon
4
Pulmonx
LUNG
$87.6M
$768K 1.5%
60,204
– –

Similar funds

M
MetLife New York $12.3M AUM 29% 1-Year Est. Return
MAMNY
Marathon Asset Management (New York) New York $12M AUM 8.79% 1-Year Est. Return
IWM
Immaculate Wealth Management Mesa, Arizona $12.7M AUM
VH
Vitol Holding Rotterdam, Netherlands $11.9M AUM 27.28% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
CCM
Crabel Capital Management Los Angeles, California $10.8M AUM 3.34% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return

ABG-WTT Global Life Science Capital Partners's Q4 2023 Portfolio in Review

As of Q4 2023, ABG-WTT Global Life Science Capital Partners held 4 positions worth $51.3M, up 146% from $20.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 0%. ABG-WTT Global Life Science Capital Partners opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • ABG-WTT Global Life Science Capital Partners's ten largest holdings make up 100% of its $51.3M portfolio in Q4 2023.
  • ABG-WTT Global Life Science Capital Partners opened 0 new positions and closed 0 in Q4 2023.
  • ABG-WTT Global Life Science Capital Partners's portfolio value rose 146% quarter-over-quarter to $51.3M.

Based on ABG-WTT Global Life Science Capital Partners's 13F filing for Q4 2023, filed 14 Feb 2024.